An accidental liraglutide overdose: case report.
作者信息
Elmehdawi Rafik R, Elbarsha Abdulwahab M
机构信息
Department of Medicine Faculty of Medicine Benghazi University Benghazi, Libya; Department of Medicine Benghazi Medical Center Benghazi, Libya.
Department of Medicine Faculty of Medicine Benghazi University Benghazi, Libya; Department of Medicine Benghazi Medical Center Benghazi, Libya;
出版信息
Libyan J Med. 2014 Jan 20;9(1):23055. doi: 10.3402/ljm.v9.23055. eCollection 2014.
Abstract
摘要
相似文献
1
An accidental liraglutide overdose: case report.一例利拉鲁肽意外过量用药病例报告。
Libyan J Med. 2014 Jan 20;9(1):23055. doi: 10.3402/ljm.v9.23055. eCollection 2014.
2
Attempted suicide with liraglutide overdose did not induce hypoglycemia.过量使用利拉鲁肽自杀并未导致低血糖。
Diabetes Res Clin Pract. 2013 Jan;99(1):e3-4. doi: 10.1016/j.diabres.2012.10.017. Epub 2012 Nov 11.
3
[A 45-fold liraglutide overdose did not cause hypoglycaemia].利拉鲁肽过量45倍未引发低血糖
Ugeskr Laeger. 2015 Jan 26;177(5):V11140595.
4
Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis.胰高血糖素样肽-1受体激动剂在2型糖尿病治疗中的疗效与安全性：一项系统评价和混合治疗比较分析
Diabetes Obes Metab. 2017 Apr;19(4):524-536. doi: 10.1111/dom.12849. Epub 2017 Feb 17.
5
Is insulin the most effective injectable antihyperglycaemic therapy?胰岛素是最有效的注射类降糖治疗药物吗？
Diabetes Obes Metab. 2015 Feb;17(2):145-51. doi: 10.1111/dom.12402. Epub 2014 Nov 9.
6
Long-term effectiveness and safety of liraglutide in clinical practice.利拉鲁肽在临床实践中的长期有效性和安全性。
Minerva Endocrinol. 2013 Mar;38(1):103-12.
7
A network meta-analysis to compare glycaemic control in patients with type 2 diabetes treated with exenatide once weekly or liraglutide once daily in comparison with insulin glargine, exenatide twice daily or placebo.一项网络荟萃分析比较了每周一次接受艾塞那肽或每日一次接受利拉鲁肽治疗与每日一次接受甘精胰岛素、每日两次接受艾塞那肽或安慰剂治疗的 2 型糖尿病患者的血糖控制情况。
Diabetes Obes Metab. 2013 Mar;15(3):213-23. doi: 10.1111/dom.12007. Epub 2012 Oct 3.
8
Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes.比较甘精胰岛素和利拉鲁肽联合口服药物治疗血糖控制不佳的 2 型糖尿病患者的疗效。
Diabetes Obes Metab. 2015 Feb;17(2):170-8. doi: 10.1111/dom.12406. Epub 2014 Dec 7.
9
[Effect of liraglutide on glucagon secretion in obese type 2 diabetic patients].利拉鲁肽对肥胖2型糖尿病患者胰高血糖素分泌的影响
Zhonghua Nei Ke Za Zhi. 2019 Jan 1;58(1):33-38. doi: 10.3760/cma.j.issn.0578-1426.2019.01.006.
10
One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target.根据糖化血红蛋白目标值，在二甲双胍的基础上加用利拉鲁肽，之后再换用胰岛素地特胰岛素，可实现 2 型糖尿病患者的 1 年持续血糖控制和体重减轻。
J Diabetes Complications. 2013 Sep-Oct;27(5):492-500. doi: 10.1016/j.jdiacomp.2013.04.008. Epub 2013 Jun 6.
引用本文的文献
1
Exploring Hypoglycemic Ketoacidosis in Nondiabetic Patients on Tirzepatide: Is Starvation the Culprit?探索使用替尔泊肽的非糖尿病患者中的低血糖性酮症酸中毒：饥饿是罪魁祸首吗？
Am J Case Rep. 2024 Dec 17;25:e946133. doi: 10.12659/AJCR.946133.
2
Accidental Once-Daily Use of Dulaglutide: A Case Report.度拉糖肽意外每日一次使用：一例报告
Clin Diabetes. 2024 Summer;42(3):454-457. doi: 10.2337/cd23-0035. Epub 2024 Jan 12.
3
GLP-1 Receptor Agonist Exposures Are Increasingly Common and Generally Associated with Mild Symptoms: A Single Poison Center Experience.GLP-1 受体激动剂暴露越来越常见，且通常与轻微症状相关：单一中毒中心的经验。
J Med Toxicol. 2024 Jul 11;20(3):278-285. doi: 10.1007/s13181-024-01008-x. Epub 2024 Jun 11.
4
Liraglutide overdose: A case report and an updated review.利拉鲁肽过量：一例病例报告及最新综述
Turk J Emerg Med. 2020 Jan 28;20(1):46-49. doi: 10.4103/2452-2473.276386. eCollection 2020 Jan-Mar.
5
Adverse Effects of GLP-1 Receptor Agonists.胰高血糖素样肽-1受体激动剂的不良反应
Rev Diabet Stud. 2014 Fall-Winter;11(3-4):202-30. doi: 10.1900/RDS.2014.11.202. Epub 2015 Feb 10.
本文引用的文献
1
10-fold liraglutide overdose over 7 months resulted only in minor side-effects.7个月内10倍剂量的利拉鲁肽过量服用仅导致轻微副作用。
J Clin Pharmacol. 2013 Jul;53(7):785-6. doi: 10.1002/jcph.94. Epub 2013 Jun 3.
2
Attempted suicide with liraglutide overdose did not induce hypoglycemia.过量使用利拉鲁肽自杀并未导致低血糖。
Diabetes Res Clin Pract. 2013 Jan;99(1):e3-4. doi: 10.1016/j.diabres.2012.10.017. Epub 2012 Nov 11.
3
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2型糖尿病高血糖管理：以患者为中心的方法：美国糖尿病协会（ADA）和欧洲糖尿病研究协会（EASD）的立场声明
Diabetes Care. 2012 Jun;35(6):1364-79. doi: 10.2337/dc12-0413. Epub 2012 Apr 19.
4
Liraglutide: clinical pharmacology and considerations for therapy.利拉鲁肽：临床药理学及治疗相关考虑。
Pharmacotherapy. 2011 Sep;31(9):896-911. doi: 10.1592/phco.31.9.896.
Zotero 插件